WES:ASXWesfarmers Limited Analysis
Data as of 2026-08-08 - not real-time
A$90.10
Latest Price
3/10Risk
Risk Level: Low
Executive Summary
Wesfarmers Limited is priced at AUD 90.10 and its moving averages line up in bullish order, the shorter sitting above the longer. RSI sits at 53.1, which reads as neutral, and MACD momentum is bearish. Price has been bracketed by support at AUD 86.01 and resistance at AUD 93.25.
The shares look overvalued at 33.4 times earnings, though no sector average was available for comparison. The average analyst target implies 14.7% below today's level. Revenue is growing at 3.1% on a 6.6% profit margin. The 2.36% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 21.4%, a beta of 0.26 and a maximum drawdown of 24.8%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
The shares look overvalued at 33.4 times earnings, though no sector average was available for comparison. The average analyst target implies 14.7% below today's level. Revenue is growing at 3.1% on a 6.6% profit margin. The 2.36% dividend yield looks covered by current payout levels.
The composite risk read is 3/10, putting it in low territory. With 30-day volatility of 21.4%, a beta of 0.26 and a maximum drawdown of 24.8%, the drawdown profile is forgiving relative to most of the market. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
The horizons line up on hold — conviction 2 out of 10.
Top Market Events
Intelligent Investor1monWES - 97.00 PUT OPTION EXPIRING 20-AUG-2026 WES7O8 Wesfarmers Limited WES options are a...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 81.47
- MACD momentum is negative
Medium Term
1–3 yearsNeutral
Model confidence: 1/10
Key Factors
- Short-term moving averages stacked above long-term ones
- Trading above the 200-day average of 81.47
- Analyst targets imply -14.7% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 2/10
Key Factors
- Analyst targets imply -14.7% versus the current price
- P/E ratio of 33.4
- Return on equity of 36.4%
Key Metrics & Analysis
Financial Health
Revenue Growth3.10%
Profit Margin6.60%
P/E Ratio33.4
ROE36.39%
ROA9.00%
Debt/Equity161.51
P/B Ratio13.0
Op. Cash FlowA$4.5B
Free Cash FlowA$3.3B
Technical Analysis
TrendBullish
RSI53.1
SupportA$86.01
ResistanceA$93.25
MA 20A$90.41
MA 50A$87.65
MA 200A$81.47
MACDBearish
VolumeDecreasing
Fear & Greed Index94.82
Valuation
Fair ValueA$31.81
Target PriceA$76.84
Upside/Downside-14.71%
GradeOvervalued
TypeGrowth
Dividend Yield2.36%
Risk Assessment
Beta0.26
Volatility21.41%
Sector RiskHigh
Reg. RiskLow
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.